Sunrest Lifescience (NSE:SUNREST) Long-Term Debt: ₹119.6 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SUNREST Sunrest Lifescience Ltd NSE:SUNREST
41 GF Score
Price ₹35.00
! 5 Warning Signs
View Full Analysis

What is Sunrest Lifescience Long-Term Debt?

Sunrest Lifescience NSE:SUNREST 41 Long-Term Debt is ₹119.6 Mil as of Mar. 2026. GuruFocus rates NSE:SUNREST with a GF Score™ of 41/100. The stock has 5 warning signs investors should review.

Sunrest Lifescience's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹119.6 Mil.

Sunrest Lifescience's quarterly Long-Term Debt increased from Sep. 2024 (₹32.2 Mil) to Mar. 2025 (₹57.3 Mil) and increased from Mar. 2025 (₹57.3 Mil) to Mar. 2026 (₹119.6 Mil).

Sunrest Lifescience's annual Long-Term Debt increased from Mar. 2024 (₹34.6 Mil) to Mar. 2025 (₹57.3 Mil) and increased from Mar. 2025 (₹57.3 Mil) to Mar. 2026 (₹119.6 Mil).

Sunrest Lifescience  (NSE:SUNREST) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sunrest Lifescience Long-Term Debt Related Terms

Sunrest Lifescience Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Sunrest Lifescience's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunrest Lifescience Long-Term Debt Chart

Sunrest Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial 30.92 19.97 34.62 57.33 119.57

Sunrest Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only 0.00 34.62 32.20 57.33 119.57
NSE:SUNREST
41GF Score
Sunrest Lifescience Ltd NSE:SUNREST
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹119.6 Mil mean?
Sunrest Lifescience (NSE:SUNREST) has a Long-Term Debt of ₹119.6 Mil as of Mar. 2026.
Is Sunrest Lifescience's Long-Term Debt too high?
Sunrest Lifescience's current Long-Term Debt is ₹119.6 Mil. Overall, Sunrest Lifescience has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Sunrest Lifescience's Long-Term Debt compare to competitors?
Sunrest Lifescience's Long-Term Debt of ₹119.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Sunrest Lifescience's current Long-Term Debt is ₹119.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunrest Lifescience stock overvalued right now?
Sunrest Lifescience (NSE:SUNREST) has a current Long-Term Debt of ₹119.6 Mil. The current Long-Term Debt is ₹119.6 Mil. Sunrest Lifescience's overall GF Score™ is 41/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Sunrest Lifescience (NSE:SUNREST), the current Long-Term Debt is ₹119.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sunrest Lifescience Business Description

Address YMCA Club, Near SG Highway, D-608 West Gate, Near Brooklin Tower, Makarba, Jivraj Park, Ahmedabad, GJ, IND, 380051
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control and regulatory compliance.
41GF Score

Get the complete analysis for NSE:SUNREST

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹35.00
Price